We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Allows MedImmune to Use New Technology For Flu Vaccines
FDA Allows MedImmune to Use New Technology For Flu Vaccines
August 7, 2006
The FDA recently approved MedImmune’s supplemental biologics license application to use a new technology to develop two influenza vaccines, according to the company.